A carregar...
Bcl-2 Antagonists: A Proof of Concept for CLL Therapy
Defective apoptosis is a fundamental hallmark feature of CLL biology and is a major target of cancer therapy development. High levels of Bcl-2 family anti-apoptotic proteins are considered primarily responsible for inhibiting apoptosis in CLL cells. While several approaches were considered to select...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4152228/ https://ncbi.nlm.nih.gov/pubmed/23907405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-013-0002-4 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|